Expression of vascular endothelial growth factor in peripheral blood cells of preeclamptic women

Piia Vuorela1, Susanna Lintula, Ulf-Håkan Stenman

  • 1Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Biomedicum, Helsinki, Finland.

Insights

Preeclampsia does not alter vascular endothelial growth factor (VEGF) levels in maternal blood cells. Healthy pregnancy increases VEGF in mononuclear cells, but preeclampsia does not further impact these levels.

Area of Science:

  • Reproductive Medicine
  • Vascular Biology
  • Immunology

Background:

  • Preeclampsia is linked to platelet and endothelial dysfunction.
  • Vascular Endothelial Growth Factor (VEGF) is present in leukocytes and released by activated platelets.

Purpose of the Study:

  • To investigate the vascular endothelial growth factor (VEGF) content in peripheral blood cells of women with preeclampsia.
  • To compare VEGF levels in platelets, mononuclear cells, and granulocytes between preeclamptic, healthy pregnant, and nonpregnant women.

Main Methods:

  • Analysis of VEGF content in platelets, mononuclear white blood cells, and granulocytes from 12 preeclamptic, 19 healthy pregnant, and 20 nonpregnant women.
  • Quantification of released protein from lysed cells using enzyme-linked immunoassay (ELISA).

Main Results:

  • Platelet and granulocyte VEGF content was similar across all three groups (preeclamptic, healthy pregnant, nonpregnant).
  • Mononuclear cell VEGF content was significantly higher in healthy pregnant women compared to nonpregnant women (P < 0.05).
  • Mononuclear cell VEGF content in preeclamptic women showed a trend towards being higher than in nonpregnant women (P ≈ 0.07).

Conclusions:

  • Uncomplicated pregnancy is associated with elevated VEGF content in mononuclear cells.
  • Preeclampsia does not appear to significantly alter the VEGF content of maternal peripheral blood mononuclear cells, granulocytes, or platelets.
Abstract